Discover Magazine: Why bacteria are the new disease fighters
Bacteria are often thought of as the "bad guys" when it comes to our health, but many good bacteria are useful and needed to perform certain functions.
Researchers at the University of Cincinnati have developed a probiotic bacteria that helps to break down cancer cell's defenses, making other treatments more effective.
Nalinikanth Kotagiri, PhD, an assistant professor in UC’s James L. Winkle College of Pharmacy and a UC Cancer Center member, told Discover Magazine that engineered bacteria help to reshape the body's immune system, enabling it to better fight diseases like cancer.
“Unlike antibody-based drugs that we take only once we have a diagnosis, these engineered bacteria can be integrated into the microbiome that’s already there,” Kotagiri said.
Read the Discover Magazine story. (Note: A web login or subscription may be needed to access the article.)
Read more about Kotagiri's research.
Featured photo at top of Dr. Kotagiri working in his lab. Photo/Colleen Kelley/University of Cincinnati.
Related Stories
The subtle changes in hearing you should never ignore
July 24, 2026
It’s easy to dismiss changes in hearing as minor. But as The Washington Post recently reported, these symptoms could also signal a medical emergency that many people don’t recognize — known as sudden sensorineural hearing loss, a rapid decline in hearing that occurs suddenly or over a few days.
UC experts say proper produce washing is key defense against Cyclospora
July 24, 2026
Hamilton County Public Health reports confirmed cases of cyclosporiasis, as concerns persist. Cyclospora is a parasite that can cause a stomach illness lasting days — sometimes even weeks. University of Cincinnati medical experts say it is usually linked to contaminated water or food, often fresh produce.
What are the options for male birth control?
July 24, 2026
Despite major advances in contraception during the past several decades, responsibility for pregnancy prevention falls largely on women. As recently reported in Endocrinology Advisor, a new generation of male contraceptive candidates is advancing into early- and mid-stage clinical trials.